N4 Pharma UK Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2016-03-31
IXBRL · 71 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 71 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2015-04-01 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0035_08878121_20160331
- Source archive
- Accounts_Monthly_Data-October2016.zip
Accounts to 2015-03-31
IXBRL · 70 source facts · 7 selected values
Not assessedlegacy record
Accounts to 2015-03-31
IXBRL · 70 source facts · 7 selected values
Not assessed
legacy record
- Reporting period
- 2014-02-05 to 2015-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 20
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0023_08878121_20150331
- Source archive
- Accounts_Monthly_Data-October2015.zip
Registered details
08878121- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-02-05
- Jurisdiction
- —
- Registered office
- 2, PORTMAN STREET, LONDON, W1H 6DU, UNITED KINGDOM
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsManufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccinesLeadInnovate UK · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant£44,405awarded
Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccinesLead
Innovate UK · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant
£44,405
awarded
N4 Pharma Limitedlead£44,405
Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccinesLeadISCF · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant£44,405whole project
Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccinesLead
ISCF · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant
£44,405
whole project
N4 Pharma UK LimitedleadMedimmune Limited
Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccinesISCF · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant£44,405whole project
Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccines
ISCF · Feasibility Studies · 2018-02-01 – 2018-10-31 · with 1 other participant
£44,405
whole project
N4 Pharma UK LimitedleadMedimmune Limited
NUVEC a platform technology for the vaccine deliveryLead
Innovate UK · Feasibility Studies · 2017-01-01 – 2017-11-30
£118,509
awarded